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the battle for oocyte quality and beyond
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Abstract: The understanding of cell cycle regulation benefited greatly from omic approaches. Because the cell
cycle engine relies heavily on proteins, proteomic methods play a key role in identification of cell cycle players.
The proteomic approach delivers an enormous volume of data, but it often lacks comprehensiveness. To ensure
the comprehensiveness of results the discovery of novel proteins must be followed by functional analysis. Using
Xenopus laevis oocytes in two different proteomic screens, we have recently identified a number of proteins
whose behavior suggested specific and unexpected roles in M-phase entry. Functional analysis of EP45 identi-
fied in one of these screens has shown that M-phase entry is stimulated by Oocyte-Maturation-ENhancer (‘Omen’)
activity. The second screen suggests the presence of an antagonistic activity, which we call ‘Omre’ (Oocyte-
Maturation-REpressor). The equilibrium between Omen and Omre activities may determine the quality of
oocytes and further embryo development via participation in making the decision whether to enter oocyte mat-
uration. It remains an open question whether similar activities operate during mitotic divisions in embryonic
and adult cells. Identifying such activities in somatic cells might impact on cancer treatments. (Folia Histochem-
ica et Cytobiologica 2011, Vol. 49, No. 1, x–x)
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Introduction
The precise control of the M-phase in each cell cy-
cle is of crucial importance for correct cell cycle pro-
gression. Cell division allows the separation of DNA
duplicated during the S-phase of the cell cycle. Be-
sides DNA, cytoplasmic organelles must also be cor-
rectly distributed between two daughter cells upon
cell division. Centrioles are the crux of the microtu-
bule-organizing centrosomes, and through this ac-
tivity control the whole architecture of the cell, du-
plicating synchronously with nuclear DNA. Accord-
ingly, they are distributed with great precision, and
synchronously with chromosomes, to the daughter
cells. Recent studies have shown that the link be-
tween centrosomal and DNA cycles may be even
closer than previously thought [1]. Apparently, the
segregation of other organelles such as Golgi appa-
ratus, mitochondria, lysosomes or ER, seems to re-
quire less control (Figure 1). However, even their
partition is strictly regulated and monitored during
the M-phase. All these dynamic changes require tem-
poral and spatial regulation, which is executed by
appropriate regulatory proteins.
Thus, the key to understanding M-phase regula-
tion lies in understanding regulatory proteins, their
interactions and interrelations.
Mitotic regulatory pathways began to be elucidat-
ed when Yoshio Masui and Clement Markert discov-
ered the existence of the major M-phase regulator,
the M-phase Promoting Factor, or MPF [2]. Their
seminal study was performed on Xenopus laevis oo-
cytes and applied micromanipulations, including the
transfer of cytoplasm from one oocyte to another.
Their main conclusion was that the cytoplasmic ac-
tivity, which they called Maturation Promoting Fac-
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tor (MPF), induces M-phase entry. MPF was shown
to be universal among all eukaryotic cells, from yeast
to human. Because further studies showed that the
same MPF induces not only meiotic but also mitotic
M-phase, Maturation Promoting Factor became M-
phase Promoting Factor.
MPF was further identified as a protein kinase,
and more precisely a complex between cdc2/CDC28
gene product called CDK1 (Cyclin Dependent Kinase
1), which has an enzymatic activity, and the regulato-
ry subunit of cyclin B [3, 4]. This discovery was hon-
ored by the Nobel Prize in Physiology and Medicine
for 2001 awarded to Paul Nurse and Tim Hunt. The
third laureate of this prize, Leland Hartwell, discov-
ered the enormous complexity of MPF activation and
inactivation machinery controlled by cell cycle check-
points [5].
Since those groundbreaking days, tools such as
proteomics have been developed to study the players
in the cell cycle. Proteomics allows the analysis of
whole proteomes or selected sub-proteomes, so it is
widely used to explore the protein composition of cells
at different stages of the cell cycle, development or
pathological states and/or upon various treatments.
We used this approach to search for new mitotic reg-
ulators in Xenopus laevis oocytes.
M-phase entry in oocytes: keys to activate
MPF
Xenopus oocyte maturation is an excellent model in
which to study M-phase initiation by proteome ap-
proach due to the abundance of maternal proteins
accumulated in the oocytes during oogenesis. Fully
grown stage VI oocytes are arrested in meiotic
prophase I, and wait for an external signal triggering
initiation of the M-phase. In such immature oocytes,
MPF is already present. However, it is maintained in
an inactive form of pre-MPF because CDK1 in such
a pre-MPF complex remains phosphorylated on its
inhibitory sites of tyrosine 15 and threonine 14 by
Myt1 kinase (Figure 2, left; [6]).
Activation of pre-MPF to active MPF occurs upon
activation of a very specific phosphatase, Cdc25, de-
phosphorylating both tyrosine 15 and threonine 14 in
concert with inhibition of Myt1 kinase [7]. Both Cdc25
and Myt1 are themselves regulated by phosphoryla-
tion. Two major kinases activating Cdc25 are CDK1
itself and polo-like kinase (Plk). The third kinase in-
volved in the process is MAP kinase ERK2 (Extracel-
lulary Regulated Kinase 2; [8]). As it usually happens
in regulatory mechanisms implicating phosphorylation
and dephosphorylation, the inhibition of Cdc25 and
Myt1 relies on their dephosphorylation. This function
is fulfilled by serine/threonine phosphatase PP2A [9].
Thus, the maintenance of the pre-MPF in its inactive
state requires a well controlled equilibrium between
phosphorylation and dephosphorylation of Cdc25 and
Myt1 by the above-mentioned enzymes (Figure 2). The
major upstream player in this process is cAMP-depen-
dent protein kinase (PKA). As long as cAMP level re-
mains high, PKA activity stays high too, and the oo-
cyte is unable to activate MPF. A mixture of steroid
hormones (among which progesterone seems to play
a major role) delivered physiologically from follicular
cells, or via experimental treatment in the case of oo-
cytes isolated from the ovary, triggers a diminution of
PKA activity [10–12].
Figure 1. Interphase to M-phase transition and cell division
Figure 2. Major phosphorylation pathways involved in pre-
MPF to MPF transition in Xenopus laevis oocytes
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The molecular mechanisms involved in the relation-
ship between the inhibition of PKA and the activation
of MPF is not fully understood (Figure 2). However,
Duckworth et al. suggested that PKA participates in
MPF down regulation during the prophase arrest of
Xenopus laevis oocytes via phosphorylation of Serine
287 of Cdc25 which has an inhibitory effect on this
phosphatase [13]. Thus, the modulation of PKA activ-
ity via a hormonally regulated mechanism seems key
to the decision to maintain the prophase arrest or to
activate MPF and to enter oocyte maturation.
A new protein synthesis is a parallel pathway to
phosphorylation/dephosphorylation cascade. Protein
synthesis inhibition (similarly to inhibition of phos-
phorylation) prevents MPF activation and oocyte
maturation. One of the newly synthesized proteins
central to MPF activation is a proto-oncogene called
c-Mos. c-Mos is a serine/threonine kinase, which ac-
tivates the MAP kinase pathway terminating by
p90rsk, another kinase phosphorylating Myt1 kinase.
This phosphorylation is required for the inhibition
of Myt1, in turn necessary for MPF activation [14].
Other key proteins whose synthesis is augmented by
progesterone are the B-type cyclins. Their appear-
ance is necessary to deliver more complexes with
CDK1, which is in clear excess compared to cyclin B
at the beginning of oocyte maturation.
The extremely rapid activation of MPF is ensured
by a positive feedback between CDK1 and Cdc25.
Even a small increase in the activity of CDK1/cyclin
B complex, when single molecules of CDK1/cyclin B
become active due to the appearance of new cyclin B
molecules, induces Cdc25 and Plk phosphorylation.
When this happens, the fragile equilibrium of the
prophase arrest breaks down and the explosive acti-
vation of the remaining CDK1/cyclin B is triggered.
This is the so-called auto-amplification loop of MPF
(Figure 2, right; [15]).
Interestingly, functions of the neosynthesis of
c-Mos and cyclin B are apparently redundant, and
new synthesis of either of these proteins is suffi-
cient to activate MPF and to begin oocyte matura-
tion in Xenopus laevis [16]. Moreover, in the ab-
sence of newly synthesized c-Mos and cyclin B, the
inhibition of PKA activity cannot trigger MPF ac-
tivation [15]. This interrelation demonstrates that
M-phase initiation in the Xenopus oocyte requires
both the progesterone signal to inactivate PKA and
the burst of c-Mos and cyclin B synthesis. This is
despite the fact that in experimental conditions only
one protein out of this pair (c-Mos or cyclin B) is
absolutely necessary.
These results show the complexity of the ma-
chinery controlling M-phase entry in prophase oo-
cytes. It is important to note that the pathways in-
volved in Xenopus laevis oocyte maturation are both
based on post-translational modifications of exist-
ing proteins (phosphorylation and dephosphoryla-
tion), as well as on the appearance of new actors
(c-Mos and cyclin B).
This is not the case for all vertebrate species. For
instance, in the mouse oocyte, a new protein synthe-
sis is not necessary for activating MPF and triggering
the meiotic M-phase. Apparently, a stock of cyclin B
necessary to initiate the loop of MPF activation is
sufficient to trigger the M-phase [17]. The new cyclin
B synthesis is, however, necessary in mouse oocytes
for further progression through the first meiotic M-
phase [18].
Interestingly, younger Xenopus laevis oocytes, for
instance in stage IV, although they morphologically
resemble fully grown oocytes, and contain pre-MPF
and Cdc25 phosphatase, are unable to respond to
progesterone stimulation [19, 20]. More surprising-
ly, they possess progesterone receptors and even de-
crease the cAMP level upon progesterone action
[21]. This shows that the cause of their inability to
activate MPF is located downstream from the cAMP.
Apparently, Plk is an enzyme lacking in these oo-
cytes, which breaks the amplification loop of MPF,
preventing c-Mos synthesis and down regulation of
Myt 1 [22, 23]. Since protein deficiency determines
the state of oocyte responsiveness, a comparison
between proteomes of stage IV and VI oocytes might
well help with understanding the mechanisms in-
volved in M-phase initiation.
Comparison between proteomes of oocytes in
stage IV and VI: Omen enters the stage
Recently, we took advantage of this model system
and compared proteomes of oocytes in stage IV and
VI by a traditional 2D-gel electrophoresis, looking
for proteins lacking in stage IV. We thought that the
lack of some proteins  in stage IV oocytes could be
involved in the inability of these oocytes to enter the
M-phase (Figure 3). Indeed, the 2D-analysis showed
a couple of spots absent in the proteome of stage IV
oocytes in contrast to stage VI.
We focused our attention on a family of four spots
identified by mass spectrometry as EP45 ( Estrogen-
Regulated Protein 45) [24].
This protein was first identified in Xenopus laevis
as an estrogen-induced protein secreted to the blood
by the liver in co-ordination with vitellogenin, the
main component of yolk in oocytes [25, 26]. This char-
acteristic suggested that EP45 could be uptaken by
oocytes from the blood. Indeed, a recent proteomic
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study of yolk components in Xenopus laevis has shown
that EP45 (under the new name of Seryp) is one of
the major components of yolk granules and the ma-
jor player in regulation of the source of energy neces-
sary for embryo development [27]. On the basis of its
amino acid sequence, EP45 was classified as a mem-
ber of the serine protease inhibitors called Serpins
[26, 27]. EP45 has a histidine-rich N-terminus which
determines its high affinity for nickel [28, 29]. Thus,
it was identified as a nickel-binding protein during
studies focused on the teratogenic action of divalent
nickel independently from early Holland’s studies and
named pNiXa (protein-Ni-Xenopus-a) [28]. pNiXa,
purified from MII-arrested Xenopus laevis oocytes,
was reported to induce oocyte maturation after in-
jection into stage VI oocytes and its stimulatory ac-
tion exhibited a synergistic effect with Ras-induced
maturation [30].
This characteristic of pNiXa in conjunction with
our proteomic screen showing that this protein ac-
cumulates in oocytes between stages IV and VI
raised several questions. The first and most obvious
was why an M-phase-inducing protein already
present in oocytes does not provoke M-phase entry
by itself?
Jorgensen et al. [27] and ourselves [24] have shown
that EP45 is not synthesized in oocytes but in the liv-
er and that it is delivered to the oocytes via blood
and, probably, via follicular cells. We also have shown
that over-expression of EP45 does not induce meiot-
ic maturation either in stage IV or VI oocytes. The
capacity previously reported by Haspel et al. [30] of
pNiXa to induce M-phase entry in oocytes could oc-
cur due to contamination of the purified protein ob-
tained from oocytes in MII, which have high activity
of CDK1/cyclin B, and the whole machinery of the
M-phase stabilization necessary during MII-arrest.
Most interestingly, the EP45 over-expression in
oocytes responding moderately to progesterone clear-
ly enhances M-phase entry [24]. This kind of M-phase-
enhancing activity was previously unknown. We have
named this novel activity of EP45 the ‘oocyte matu-
ration enhancement’ activity or ‘Omen’.
Comparison between proteomes of well-
maturing and poorly-maturing oocytes:
‘Omre’ joins ‘Omen’
In parallel to the proteomic analysis of stage IV and
VI oocytes, we focused on well-maturing and poorly-
maturing stage VI oocytes [31]. We wanted to identi-
fy the proteins differentially expressed in oocytes of
different quality. During oocyte growth, numerous
proteins accumulate as a maternal store for future
use by the developing embryo. The pattern of pro-
teins accumulated in oocytes has been studied in dif-
ferent species, but no comparative studies between
oocytes showing different capacities to enter into
maturation, and thus different quality, has ever been
carried out. As we have recently found the Omen ac-
tivity enhancing M-phase entry and oocyte matura-
tion, we could expect the presence of an opposite ac-
tivty – Omre for „Oocyte maturation repressor”. Thus
we were interested in identification of proteins spe-
cifically present or abundant in poorly-maturing oo-
cytes, because such proteins could have an activity
anatgonistic to the Omen activity. In our differential
screen we found two spots specifically present in poor-
ly-maturing oocytes, which were identified as two pro-
teins: Elongation Factor 2 (EF2) and S-adenosyl-L-
homosysteine hydrolase (SAHH).
These two spots, present specifically in 2-D gels
made of poorly-maturing oocytes, most probably rep-
resent specific forms of the two proteins. It is diffi-
cult to imagine that a factor highly important to pro-
tein synthesis is absent from well-maturing oocytes.
EF2 is known to be down regulated in stage VI Xeno-
pus leavis oocytes via changes in its phosphorylation
[32]. Thus, the spot found only in poorly-maturing
oocytes suggests that EF2 may be modified in a spe-
cific way in these oocytes as opposed to well-matur-
ing ones. SAHH is known as a highly conserved and
ubiquitous enzyme hydrolyzing S-adenosylhomocys-
teine (SAH). SAH is a by-product of S-adenosylme-
thionine-dependent methylations [33]. The catalysis
Figure 3. Differential proteomic screens comparing
proteomes of (1): stage IV and VI and (2): stage VI poorly-
maturing and well-maturing Xenopus leavis oocytes
Xenopus laevis oocytes of different stage or quality
5Proteomics of M-phase entry
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2011
DOI
www.fhc.viamedica.pl
of this reaction makes SAHH a major positive regu-
lator of methylation of DNA, RNA, lipids and pro-
teins via decreasing the level of SAH [34]. Interest-
ingly, SAHH and EF2 have been identified as pro-
teins increased in another proteomic screen that
looked at the response of rat astrocytes to oxidative
stress induced by H2O2 [35]. Thus, the presence of
the additional spots of each of these proteins in poor-
ly-maturing oocytes could correlate with a response
to a stress exercised on these oocytes. Similarly to EF2,
SAHH is regulated by phosphorylation [36], which
may result in its modified electrophoretic mobility in
our 2-D gels. Thus, again only well-maturing oocytes
may contain a specific isoform of SAHH correlating
with the poor quality of oocytes.
Energy and evolution: a battle between Omen
and Omre
Omre’s potential activity needs to be verified by fur-
ther functional analysis of selected proteins [31]. It is
very tempting to imagine a battle between Omen and
Omre activities which remain in equilibrium in phys-
iologically normal cells (Figure 4).
The question also remains of how Omen activity
interacts with CDK1-activating machinery. The fact
that EP45 over-expression does not induce MPF ac-
tivation in stage VI oocytes, and does not even accel-
erate oocyte maturation, suggests that this protein is
not required for induction of the M-phase in physio-
logical conditions. The clear enhancement of matu-
ration upon suboptimal conditions, i.e. in oocytes in
which a low progesterone dose cannot efficiently in-
duce MPF activation, suggests that EP45 may act
through an unspecific pathway downstream from
progesterone receptors.
As EP45 has been shown to be involved in the reg-
ulation of yolk consumption in the embryo [27], we
propose that it may ameliorate the efficiency of the
use of energy sources needed for the cell cycle transi-
tions. Both nuclear envelope breakdown and chro-
matin assembly require adapted energy sources [37,
38]. It is also known that the meiotic program in yeast
is under the control of sources of nutrients for energy
production [39]. Moreover, it has been found in hu-
man oocytes that the number of mitochondria per
oocyte, and thus probably oocyte efficiency to pro-
duce the energy, is linked to the quality of oocyte
maturation: women suffering from ovarian insuffi-
ciency have low mtDNA content in oocytes [40]. Thus,
EP45 over-expression may facilitate M-phase induc-
tion simply by restoring the energetic status quo in
deficient or stressed oocytes. The fact that the action
of EP45 is detectable only in poorly-maturing oocytes
indicates that EP45-related activities ameliorate oo-
cyte quality. This is an important observation, which
shows that low quality oocytes have the ability to im-
prove through the action of specific activities/proteins.
EP45 is certainly not the only protein involved in
Omen activity. A number of similar activities and pro-
teins may participate establishing the status of oocyte
quality. Moreover, Omen activity may have equiva-
lents in somatic cells, and as such may influence the
ability and/or the timing of cells to enter the M-phase.
Knowledge of such molecules may impact cancerolo-
gy since the regulation of anarchic cell divisions in
tumor cells is one of the pharmacological goals in the
fight against cancer. Interestingly, the group of Will-
iam Sunderman has shown that pNiXa antibody gave
a positive staining in 21 of 181 human neoplasms, in-
cluding prostate, liver, colon, and breast tumors,
whereas the signal was absent in 119 specimens of
normal human tissues [41]. Thus an EP45-related ser-
pin (there is no clear EP45 homolog among human
serpins) may be associated with certain tumorigene-
sis. This may happen via its Omen activity. The possi-
bility of influencing the ability of tumor cells to di-
vide via manipulation of Omen and Omre activities
may open a new avenue in the battle against cancer.
Finally, the discovery of EP45 Omen activity could
impact our view of the mechanisms of evolution.
Under changing environmental conditions (e.g. fol-
lowing the abrupt appearance of hormonal disrup-
tors in water), the level of progesterone in Xenopus
laevis females may fall drastically. Such a change in
hormonal regulation may provoke a fall in the num-
ber of oocytes undergoing normal meiotic matura-
tion. This in turn would reduce the reproductive suc-
cess of females. In such a case, the originally neutral-
for-reproduction EP45-dependent processes become
important survival factors, since they may ameliorate
the quality of oocytes, embryo development and re-
productive success.
Figure 4. Hypothesis of the Omen versus Omre battle
regulating interphase to M-phase transition
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Such a mechanism resembles an evolutionary strat-
egy well described in bacteria called bet-hedging,
which is based on the stochastic presence of factors
increasing survival in a drastically changing environ-
ment [42].
To the best of our knowledge, EP45 is the first
gene product in vertebrates which could be direct-
ly involved in a bet-hedging strategy. Omen and
Omre activities are very good candidates for fac-
tors essential for a bet-hedging strategy, because
of their neutral character in normal physiological
conditions. The potential battle between Omen and
vs. Omre could thus be of significant importance
for evolution.
In conclusion, a proteomic approach may help
discover not only new proteins, but also new func-
tions and activities of those proteins. The presence
of ‘hidden’ activities such as Omen and Omre in oo-
cytes shows the necessity of developing methods to
identify and quantify proteins in individual oocytes.
This could enable a comparison of the proteomes of
selected cells in the search for proteins involved in
the quality of oocytes. We are currently working on
the development of approaches enabling the analysis
of proteomes in single cells.
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